Long-term sequelae of childhood bacterial meningitis

Current Infectious Disease Reports

Volumn 15, Issue 3, 2013, Pages 236-241

  Hudson, Lee D ^a,b   Viner, Russell M ^a,b   Christie, Deborah ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bacterial; Children; Complications; Meningitis; Outcomes

Indexed keywords

ANTIBIOTIC AGENT; BCG VACCINE; CORTICOSTEROID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE;

ARTICLE; BACTERIAL MENINGITIS; CHILD CARE; COGNITIVE DEFECT; EPIDEMIC MENINGITIS; EVIDENCE BASED MEDICINE; FOLLOW UP; GROUP B STREPTOCOCCAL MENINGITIS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS MENINGITIS; HEALTH CARE ACCESS; HEALTH PROGRAM; HEARING IMPAIRMENT; HUMAN; INFECTION PREVENTION; MOTOR DYSFUNCTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PNEUMOCOCCAL MENINGITIS; SEIZURE; SOCIAL STATUS; STREPTOCOCCUS AGALACTIAE; TUBERCULOUS MENINGITIS; VACCINATION; VISUAL IMPAIRMENT;

EID: 84878741749     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-013-0332-6     Document Type: Article

References (39)

1. Greenwood B. Editorial: 100 years of epidemic meningitis in West Africa-has anything changed? Trop Med Int Health. 2006;11(6):773-80.
2. Booy R, Habibi P, Nadel S, De Munter C, Britto J, Morrison A, et al. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child. 2001;85(5):386-90.
3. Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009;27:B51-63.
4. Dery MA, Hasbun R. Changing epidemiology of bacterial meningitis. Curr Infect Dis Rep. 2007;9(4):301-7.
5. Nadel S. Prospects for eradication of meningococcal disease. Arch Dis Child. 2012;97(11):993-98.
6. Levine OS, O'Brien KL, Knoll M, Adegbola RA, Black S, Cherian T, et al. Pneumococcal vaccination in developing countries. Lancet. 2006;367(9526):1880.
7. Stephens DS. Conquering the meningococcus. FEMS Microbiol Rev. 2007;31(1):3-14.
8. Gerber J, Nau R. Mechanisms of injury in bacterial meningitis. Curr Opin Neurol. 2010;23(3):312.
9. Sharshar T, Carlier R, Bernard F, Guidoux C, Brouland JP, Nardi O, et al. Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med. 2007;33(5):798-806.
10. Henke K, Buck A, Weber B, Wieser HG. Human hippocampus establishes associations in memory. Hippocampus. 1998;7(3):249-56.
11. Shears D, Nadel S, Gledhill J, Garralda ME. Short-term psychiatric adjustment of children and their parents following meningococcal disease. Pediatr Crit Care Med. 2005;6(1):39-43.
12. •• Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(5):317-28. This study is a systematic review which included a large number of studies and sorts risk of sequelae by pathogen. Some studies may have included adults, though most were children.
13. Sumpter R, Brunklaus A, McWilliam R, Dorris L. Health-related quality-of-life and behavioural outcome in survivors of childhood meningitis. Brain Inj. 2011;25(13-14):1288-95.
14. Pelkonen T, Roine I, Monteiro L, Correia M, Pitkäranta A, Bernardino L, et al. Risk factors for death and severe neurological sequelae in childhood bacterial meningitis in sub-Saharan Africa. Clin Infect Dis. 2009;48(8):1107-10.
15. McCormick DW, Wilson ML, Mankhambo L, Phiri A, Chimalizeni Y, Kawaza K, et al. Risk factors for death and severe sequelae in Malawian children with bacterial meningitis, 1997-2010. Pediatr Infect Dis J. 2012;(2):e54-61.
16. Lucey J, Gavin P, Cafferkey M, Butler K. Pneumococcal meningitis: clinical outcomes in a pre-vaccine era at a Dublin paediatric hospital, 1999-2007. Ir J Med Sci. 2011;180(1):47-50.
17. Legood R, Coen PG, Knox K, Viner RM, El Bashir H, Christie D, et al. Health related quality of life in survivors of pneumococcal meningitis. Acta Paediatr. 2008;98(3):543-7.
18. Kihara M, de Haan M, Were EO, Garrashi HH, Neville BGR, Newton CRJC. Cognitive deficits following exposure to pneumococcal meningitis: an event-related potential study. BMC Infect Dis. 2012;12(1):79.
19. Borg J, Christie D, Coen PG, Booy R, Viner RM. Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study. Pediatrics. 2009;123(3):e502-9.
20. •• Viner RM, Booy R, Johnson H, Edmunds WJ, Hudson L, Bedford H, et al. Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study. Lancet Neurol. 2012;11(9):774-83. This study used case control to describe outcomes in meningitis with Meningococcal Type B: of important relevance to the predominant caused of illness in high income countries at present.
21. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Global burden of tuberculosis. JAMA: J Am Med Assoc. 1999;282(7):677-86.
22. van Well GTJ, Paes BF, Terwee CB, Springer P, Roord JJ, Donald PR, et al. Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa. Pediatrics. 2009;123(1):e1-8.
23. Andronikou S, Greyling PJ. Devastating yet treatable complication of tuberculous meningitis: the resistant TB abscess. Childs Nerv Syst. 2009;25(9):1105-6.
24. Schoeman J, Hons MB, Zyl F, Fertig G, Rensburg AJ, Springer P, et al. Long-term follow up of childhood tuberculous meningitis. Dev Med Child Neurol. 2002;44(8):522-6.
25. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342(1):15-20.
26. Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J. 2008;27(12):1057-64.
27. Levent F, Baker CJ, Rench MA, Edwards MS. Early outcomes of group B streptococcal meningitis in the 21st century. Pediatr Infect Dis J. 2010;29(11):1009.
28. Libster R, Edwards KM, Levent F, Edwards MS, Rench MA, Castagnini LA, et al. Long-term outcomes of Group B streptococcal meningitis. Pediatrics. 2012;130(1):e8-e15.
29. Tunkel A, Scheld W. Acute bacterial meningitis. Lancet. 1995;346(8991-8992):1675.
30. Lebel MH, Freij BJ, Syrogiannopoulos GA, Chrane DF, Hoyt MJ, Stewart SM, et al. Dexamethasone therapy for bacterial meningitis. N Engl J Med. 1988;319(15):964-71.
31. Odio CM, Faingezicht I, Paris M, Nassar M, Baltodano A, Rogers J, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med. 1991;324(22):1525-31.
32. Prasad K, Singh M. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2008;(1):CD002244.
33. Esposito S, Semino M, Picciolli I, Principi N. Should corticosteroids be used in bacterial meningitis in children? Eur J Paediatr Neurol. 2012.
34. Visintin C, Mugglestone MA, Fields EJ, Jacklin P, Murphy MS, Pollard AJ. Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance. BMJ. 2010;340:c3209.
35. Theilen U, Wilson L, Wilson G, Beattie J, Qureshi S, Simpson D. Guidelines: management of invasive meningococcal disease in children and young people: summary of SIGN guidelines. BMJ: Br Med J. 2008;336(7657):1367.
36. Wu XR, Yin QQ, Jiao AX, Xu BP, Sun L, Jiao WW, et al. Pediatric tuberculosis at Beijing Children's Hospital: 2002-2010. Pediatrics. 2012;130(6):e1433-40.
37. Driver CR, Luallen JJ, Good WE, Valway SE, Frieden TR, Onorato IM. Tuberculosis in children younger than five years old: New York City. Pediatr Infect Dis J. 1995;14(2):112.
38. Roberts L. Costs of meningitis outbreaks are crippling, too. Science. 2008;320(5884):1712.
39. Sweeney F, Viner RM, Booy R, Christie D. Parents' experiences of support during and after their child's diagnosis of Meningococcal Disease. Acta Paediatrica. 2013;102(3):e126-30.